4Suppliers
2Customers
1Debt Items
9Related Chains

Source-Backed Evidence Depth

HUTCHMED (China) Ltd (HMDCF) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

7Total relationships
1Distinct source URLs
1High confidence
0.746Average confidence
2026-09-22Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

HUTCHMED (China) Ltd Suppliers

TickerNameConfidenceEvidence
HCM HUTCHMED (China) Limited 72% nts regarding: ● the initiation, timing, progress and results of our or our collaboration partners ’ pre-clinical and clinical studies, and our research and development programs; ● our or our collabo…
HCM HUTCHMED (China) Limited 72% Reciprocal relationship from HCM graph: Reciprocal relationship from HMDCF graph: nts regarding: ● the initiation, timing, progress and results of our or our collaboration partners ’ pre-clinical and…
RIGL Rigel Pharmaceuticals, Inc. 72% ber 14, 2021 to set aside the final award which was heard by the High Court in Hong Kong on June 28, 2022 and dismissed by the judge on July 26, 2022. Luye obtained leave to appeal the setting aside …
RIGL Rigel Pharmaceuticals, Inc. 72% Reciprocal relationship from RIGL graph: Reciprocal relationship from HMDCF graph: ber 14, 2021 to set aside the final award which was heard by the High Court in Hong Kong on June 28, 2022 and dismis…

HUTCHMED (China) Ltd Customers

TickerNameConfidenceEvidence
RIGL Rigel Pharmaceuticals, Inc. 72% ber 14, 2021 to set aside the final award which was heard by the High Court in Hong Kong on June 28, 2022 and dismissed by the judge on July 26, 2022. Luye obtained leave to appeal the setting aside …
RIGL Rigel Pharmaceuticals, Inc. 72% Reciprocal relationship from RIGL graph: Reciprocal relationship from HMDCF graph: Reciprocal relationship from RIGL graph: Reciprocal relationship from HMDCF graph: ber 14, 2021 to set aside the fin…

HUTCHMED (China) Ltd Debt Obligations

InstrumentDescriptionConfidenceEvidence
HMDCF-DEBT-10039 Warrants outstanding: 6 90% xbrl warrant detail from xbrl 2022-12-31.

HUTCHMED (China) Ltd Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for HUTCHMED (China) Ltd.

HUTCHMED (China) Ltd Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for HUTCHMED (China) Ltd.

HUTCHMED (China) Ltd Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
RIGL Rigel Pharmaceuticals, Inc. 100.00 1 ['customer', 'supplier']
HCM HUTCHMED (China) Limited 100.00 1 ['supplier']
CAH Cardinal Health, Inc. 50.00 2
CRIS Curis, Inc. 50.00 2
SNYNF Sanofi 50.00 2
VOR Vor Biopharma Inc. 50.00 2
AZN AstraZeneca PLC 50.00 2
MCK McKesson Corporation 50.00 2
ORANY ORANGE 50.00 2
🔐
HMDCF
Unlock HMDCF Supply Chain Data
Verified relationships include:
HCMHUTCHMED (China) LimitedSupplier72%
HCMHUTCHMED (China) LimitedSupplier72%
RIGLRigel Pharmaceuticals, Inc.Customer72%
RIGLRigel Pharmaceuticals, Inc.Customer72%
+3 more relationships locked
Subscribe — View plans →